No of samples | Tumor type | Age category | Summary | Ref. |
---|---|---|---|---|
41 | mixed LGG | C/A | 61 differently expressed miRNAs on profiling study (n = 41); the same samples (n = 19) used for validation of miR-129-2-3p, miR-219-5p, miR-338-3p, miR-487b, miR-885-5p, miR-323a-3p, miR-4488 and miR-1246; expression of miR-487b from cluster 14q32.31 variably underexpressed in pediatric glioma lines | [24] |
34 | GG | C/A | evaluation of inflammation-related miR-21, miR-146, miR-155; miR-146 contributed to epileptogenic network | [25] |
29 | GG | C/A | 66 miRNAs differently expressed on profiling study (n = 9); validation (n = 20) of miR-217 showed relationship between miR-217 and ERK1/2 | [22] |
5 | DNET | C | 120 differently expressed miRNAs on profiling study (n = 5); the same samples used for validation aof down-regulated miR-3138 and overexpressed miR-1909 | [23] |
43 | PA | C/YA | 31 differently expressed miRNAs on profiling study (n = 43); validation of miR-21, miR-124 and mir-129 (n = 9) | [12] |
99 | mixed LGG | C/A | miR-519d and miR-4758 upregulated in GGs compared to control tissue, DNET and other gliomas | [50] |